{
    "title": "Lilly's blockbuster Mounjaro boosts third quarter results, supply issues persist",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-12701817/Eli-Lilly-beats-quarterly-revenue-estimates-Mounjaro-strength.html",
    "date": "2023-11-02",
    "keywords": [
        "mounjaro",
        "drug",
        "year",
        "company",
        "time",
        "demand",
        "loss",
        "profit",
        "thursday",
        "capacity",
        "share",
        "end",
        "quarter",
        "trulicity",
        "bhanvi",
        "satija",
        "approval",
        "ashkenazi",
        "market",
        "decision",
        "donanemab",
        "wingrove",
        "offlabel",
        "surprise",
        "thirdquarter",
        "drugmaker",
        "supply",
        "healthcare",
        "success",
        "trading",
        "basis",
        "obesity",
        "treatment",
        "finance",
        "anat",
        "manufacturing",
        "ramp",
        "week",
        "production",
        "situation",
        "cfo",
        "interview",
        "rival",
        "nordisk",
        "race",
        "slice",
        "antiobesity",
        "class",
        "glp1",
        "wegovy",
        "term",
        "beat",
        "boon",
        "whole",
        "point",
        "vial",
        "analyst",
        "evan",
        "majority",
        "fda",
        "pipeline",
        "charge",
        "range",
        "forecast",
        "cut",
        "continuation",
        "lillys",
        "promise",
        "deliver",
        "strategy",
        "bmos",
        "seigerman",
        "revenue",
        "street",
        "reporting",
        "bengaluru",
        "editing",
        "shinjini",
        "ganguli",
        "bill",
        "berkrot"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}